1. Home
  2. AEHR vs CSTL Comparison

AEHR vs CSTL Comparison

Compare AEHR & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aehr Test Systems

AEHR

Aehr Test Systems

HOLD

Current Price

$89.83

Market Cap

858.8M

Sector

Industrials

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$24.51

Market Cap

806.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AEHR
CSTL
Founded
1977
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
858.8M
806.3M
IPO Year
1997
2019

Fundamental Metrics

Financial Performance
Metric
AEHR
CSTL
Price
$89.83
$24.51
Analyst Decision
Hold
Strong Buy
Analyst Count
3
6
Target Price
$29.50
$45.50
AVG Volume (30 Days)
4.3M
251.6K
Earning Date
04-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$58,968,000.00
$344,229,000.00
Revenue This Year
N/A
$2.42
Revenue Next Year
$71.04
$12.69
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.66
52 Week Low
$8.02
$14.59
52 Week High
$102.48
$44.28

Technical Indicators

Market Signals
Indicator
AEHR
CSTL
Relative Strength Index (RSI) 68.14 45.88
Support Level $21.95 $21.77
Resistance Level N/A $26.20
Average True Range (ATR) 8.35 0.95
MACD -0.70 0.18
Stochastic Oscillator 63.80 57.83

Price Performance

Historical Comparison
AEHR
CSTL

About AEHR Aehr Test Systems

Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Share on Social Networks: